Non-pharmacological treatment of idiopathic pulmonary fibrosis

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fatal disorder that remains difficult to treat. In this review, we examine non-pharmacological treatment modalities, including lung transplantation, pulmonary rehabilitation and palliation. Lung transplantation, the only therapeutic intervention that offers survival benefit, should be considered in all IPF patients with progressive disease who meet the International Society for Heart and Lung transplantation guidelines. Pulmonary rehabilitation improves exercise capacity, reduces dyspnoea and improves quality of life in IPF patients, and should be made available to patients. For those patients with advanced disease, palliative services offer symptom management, improved quality of life and psychological support for patients and their caregivers.